Stone House Investment Management »

First Tracks Biotherapeutics shares owned by Stone House Investment Management

Quarter-by-quarter ownership of First Tracks Biotherapeutics (TRAX) shares owned by Stone House Investment Management from 13F filings

Historical chart of Stone House Investment Management investment in First Tracks Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including First Tracks Biotherapeutics held by Stone House Investment Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in First Tracks Biotherapeutics by Stone House Investment Management

Quarter filed Position value Share count Share price at filing
2026-06-30 $60 3 20.00

More positions owned by Stone House Investment Management

Ishares Tr Core S&p500 Etf (IVV)
Ishares Tr Core Univrsl Usd (IUSB)
Spdr Series Trust St Str P500etf (SPYM)
Ishares Tr S&p 500 Grwt Etf (IVW)
Blackrock Etf Trust Ishares Us Equit (DYNF)
Ishares Tr S&p 500 Val Etf (IVE)
Fidelity Merrimack Str Tr Total Bd Etf (FBND)
Ishares Tr Core Msci Total (IXUS)
Procter & Gamble Company (PG)
Ishares Core Msci Emkt (IEMG)
Ishares Tr Eafe Grwth Etf (EFG)
Blackrock Etf Trust Isha I In Te Etf (BAI)
Fidelity Covington Trust Enhanced Intl (FENI)
Ishares Tr Core S&p Mcp Etf (IJH)
Ishares Tr Msci Usa Mmentm (MTUM)

View all positions for Stone House Investment Management

Top funds holding First Tracks Biotherapeutics

EcoR1 Capital
TCG Crossover Management
FMR
Affinity Asset Advisors
BlackRock
Trails Edge Capital Partners
Vanguard Capital Management
Jupiter Topco
Vestal Point Capital
Woodline Partners
Sanofi
683 Capital Management
Adage Capital Partners GP
Balyasny Asset Management
Geode Capital Management

View all funds holding First Tracks Biotherapeutics